相关实验视频

Updated: Jun 30, 2026

Identification of Metabolically Active Bacteria in the Gut of the Generalist Spodoptera littoralis via DNA Stable Isotope Probing Using 13C-Glucose

Identification of Metabolically Active Bacteria in the Gut of the Generalist Spodoptera littoralis via DNA Stable Isotope Probing Using 13C-Glucose

Published on: November 13, 2013

在土壤中挖掘菌根菌并寻找抗糖尿病代谢产物来源

Fatemeh Saadatpour¹, Mohammad Hossain Nikzad¹, Fatemeh Salimi²

¹Pharmaceutial Biotechnology Lab, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran.

Folia microbiologica

|July 21, 2023

概括

菌的二次代谢产物显示出抗糖尿病药物发现的潜力. 菌株UTMC 4530显著抑制了糖尿病标志物和葡萄糖吸附,没有观察到毒性.

科学领域:

微生物学微生物学
自然产品化学自然产品化学
药理学药理学是指药理学的学科.

背景情况:

菌根菌产生各种不同的二次代谢产物,具有独特的结构.
这些化合物是新药发现的潜在来源,包括抗糖尿病药物.

研究的目的:

为了研究菌分离物作为抗糖尿病药物发现的来源.
识别和表征具有抗糖尿病特性的菌株菌株菌株.

主要方法:

从土壤样本中分离和分类菌群菌的分类学分类.
提取和选二次代谢物的抗糖尿病活性.
在体外测定碳基和果胺形成的抑制,α-葡萄糖酶和α-氨基酶的抑制,葡萄糖吸附,激素清除和细胞毒性.

主要成果:

获得了33个myxobacterial分离物,这些分离物属于Myxococcus,Corallococcus和Cystobacter等属.
Myxobacterium UTMC 4530 显示显著抑制碳基和果胺的形成.
UTMC 4530显示对α-葡萄糖酶 (23%) 和α-氨基酶 (15.8%) 的抑制活性,诱导葡萄糖吸附 (35%),并且在细胞毒性测定中没有表现出毒性.
菌株UTMC 4530与Corallococcus llansteffanensis的相似性为87.3%,这表明它可能代表一个新的属.

结论:

来自myxobacterium UTMC 4530的二次代谢产物具有多种抗糖尿病活性.
菌株UTMC 4530是开发用于糖尿病管理的新治疗剂的有希望的来源.
对这些代谢物的进一步研究可能会导致新的制药应用.

关键词:

抗糖尿病生物测试抗糖尿病生物测试细胞毒性细胞毒性糖尿病糖尿病糖尿病炎症炎症是一种炎症.菌菌菌的存在菌菌菌的存在人类的家谱 (Phylogeny) 是一个学科.二次代谢产物二次代谢产物

更多相关视频

Exploring the Root Microbiome: Extracting Bacterial Community Data from the Soil, Rhizosphere, and Root Endosphere

Exploring the Root Microbiome: Extracting Bacterial Community Data from the Soil, Rhizosphere, and Root Endosphere

Published on: May 2, 2018

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Published on: March 31, 2021

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...